Evaluating Shoulder Chuna Therapy for Pain from Traffic Accidents
The Efficacy and Safety of Shoulder Chuna on in Patients with Shoulder Pain Caused by Traffic Accidents: a Pragmatic Randomized Controlled Trial
This study is testing whether Chuna therapy can help people with shoulder pain and limited movement after a traffic accident feel better and recover faster compared to another treatment.
Quick facts
| Phase | Not applicable |
|---|---|
| Study type | Interventional |
| Enrollment | 98 (estimated) |
| Ages | 19 Years to 69 Years |
| Sex | All |
| Sponsor | Jaseng Medical Foundation Academic / other |
| Locations | 1 site (Seoul, Gangnam-Gu) |
| Trial ID | NCT06624800 on ClinicalTrials.gov |
What this trial studies
This study aims to assess the effectiveness of Chuna therapy in treating acute shoulder pain and restricted movement resulting from traffic accidents. It is a double-blind, randomized controlled trial where participants will receive either shoulder Chuna therapy or Korean integrative medicine treatment. The therapy will be administered from the second day of hospitalization until discharge, focusing on pain relief, recovery of range of motion, and overall patient satisfaction. The study seeks to fill a gap in research regarding the application of Chuna therapy specifically for shoulder injuries.
Who should consider this trial
Good fit: Ideal candidates are hospitalized patients aged 19-69 with acute shoulder pain and restricted movement occurring within 5 days after a traffic accident.
Not a fit: Patients with serious underlying conditions causing shoulder pain or those who have had recent shoulder surgeries may not benefit from this study.
Why it matters
Potential benefit: If successful, this study could provide an effective non-surgical treatment option for patients suffering from shoulder pain due to traffic accidents.
How similar studies have performed: While the effectiveness of Korean medicine for trauma has been studied, this specific application of Chuna therapy for shoulder pain is relatively novel and has not been extensively researched.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Patients aged 19-69 years on the date they sign the consent form. * Patients with shoulder pain and restricted movement occurring within 5 days after a traffic accident. * Patients who are hospitalized due to traffic accident. * Patients with NRS of shoulder pain ≥ 5 with restricted movement due to a traffic accident. * Patients who provide consent to participate in the trial and return the informed consent form. Exclusion Criteria: * Patients with a specific serious disease that may cause shoulder pain: malignancy, spondylitis, inflammatory spondylitis, etc. * Patients with progressive neurological deficits or with severe neurological symptoms. * Patients with medical history of cervical surgery or shoulder surgery within the last three weeks. * Patients with a specific serious disease that may interfere with the interpretation of the therapeutic effects or results: malignancy, spondylitis, inflammatory spondylitis, etc. * Chuna therapy is deemed inappropriate or unsafe due to conditions like fractures, dislocations, ligament tears, or unstable healing fractures; skeletal demineralization and ligament laxity with subluxation or dislocation; or inflammation * Presence of other chronic diseases that could interfere with treatment outcomes or interpretation, such as cardiovascular disease, kidney disease, diabetic neuropathy, dementia, or epilepsy * Currently taking steroids, immunosuppressants, psychiatric medications, or other drugs that may affect study results * Acupuncture is deemed inappropriate or unsafe, such as in patients with bleeding disorders, those on anticoagulant therapy, those with severe diabetes prone to infection, or those with severe cardiovascular disease * Patients who are pregnant or planning to become pregnant. * Patients who are presence of severe mental illness * Patients who are participated in clinical trials other than observational studies without therapeutic intervention. * Patients who are difficult to complete the research participation agreement. * Other patients whose participation in the trial is judged by a researcher to be problematic.
Where this trial is running
Seoul, Gangnam-Gu
- Jaseng Hospital of Korean Medicine — Seoul, Gangnam-Gu, Korea, Republic of (Recruiting)
Study contacts
- Study coordinator: In-Hyuk In-Hyuk Ha, phD
- Email: hanitata@jaseng.co.kr
- Phone: 02-2222-2740
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.